Related Experiment Video
Updated: Jun 2, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Relationship between serum cystatin C and hypertension among US adults without clinically recognized chronic kidney
Anoop Shankar1, Srinivas Teppala
1Department of Community Medicine, West Virginia University School of Medicine, Morgantown, WV, USA. ashankar@hsc.wvu.edu
Insights
Mildly reduced kidney function, indicated by higher serum cystatin C, is linked to hypertension in women but not men, even before chronic kidney disease (CKD) is clinically apparent.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Epidemiology
Background:
- Animal studies suggest a link between reduced renal function and hypertension.
- Few human studies have investigated this association, particularly in individuals without clinically recognized chronic kidney disease (CKD).
- Serum cystatin C is a marker of glomerular filtration rate (GFR).
Purpose of the Study:
- To examine the association between serum cystatin C levels and hypertension in US adults without clinically recognized CKD.
- To determine if this association differs between men and women.
Main Methods:
- Analysis of data from the National Health and Nutrition Examination Survey (1999-2002) on 2583 US adults (>20 years).
- Exclusion of participants with estimated GFR <60 mL/min/1.73 m² or microalbuminuria.
- Hypertension defined by medication use or blood pressure thresholds (≥140/90 mm Hg).
- Serum cystatin C levels categorized into quartiles; multivariable adjustments performed.
Main Results:
- Higher serum cystatin C levels were significantly associated with hypertension in women (OR 2.04, 95% CI 1.13-3.69 for Q4 vs Q1; P trend = .02).
- No significant association was found between serum cystatin C levels and hypertension in men (OR 0.86, 95% CI 0.53-1.41; P trend = .51).
- These findings persisted after adjusting for multiple confounding factors.
Conclusions:
- Mildly reduced kidney function, as indicated by elevated serum cystatin C, is associated with hypertension in US women without clinically recognized CKD.
- This association was not observed in men.
- Serum cystatin C may serve as an early indicator of hypertension risk in women, independent of established CKD markers.
Abstract:
Previous animal studies have suggested that mild reductions in renal function, even before the development of clinically recognized chronic kidney disease (CKD), are associated with hypertension. However, few studies have examined this hypothesis in humans. We therefore examined the association between serum cystatin C levels and hypertension among subjects without clinically recognized CKD in a large multiethnic sample of US adults. We examined the National Health and Nutrition Examination Survey 1999-2002 participants >20 years of age (n = 2583, 54.5% women) without clinically recognized CKD (defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2) or microalbuminuria). Serum cystatin C levels were categorized into quartiles (<0.76 mg/L, 0.76-0.86 mg/L, 0.87-0.97 mg/L, and >0.97 mg/L). Hypertension was defined as blood pressure (BP)-reducing medication use or having systolic BP ≥ 140 mm Hg and/or diastolic BP ≥ 90 mm Hg. Higher serum cystatin C levels were found to be associated with hypertension in women, but not men. After adjusting for age, race-ethnicity, education, smoking, alcohol intake, body mass index, diabetes, total cholesterol and C-reactive protein, the odds ratio (95% confidence interval) of hypertension comparing quartile 4 of cystatin C to quartile 1 (referent) was 2.04 (1.13-3.69); P trend = .02 in women and 0.86 (0.53-1.41); P trend = .51 in men. In a representative sample of US adults, mild reductions in kidney function as measured by higher serum cystatin C levels among subjects without clinically recognized CKD are associated with hypertension in women, but not men.
Related Concept Videos
Serum Studies: Renal Function Tests
Chronic Kidney Disease I: Introduction
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Chronic Kidney Disease III: Interprofessional Care